| Year |
Citation |
Score |
| 2024 |
Ceyhan B, Nategh P, Neghabi M, LaMar JA, Konjalwar S, Rodriguez P, Hahn MK, Gross M, Grumbar G, Salleng KJ, Blakely RD, Ranji M. Optical Imaging Demonstrates Tissue-Specific Metabolic Perturbations in Mblac1 Knockout Mice. Ieee Journal of Translational Engineering in Health and Medicine. 12: 298-305. PMID 38410184 DOI: 10.1109/JTEHM.2024.3355962 |
0.498 |
|
| 2023 |
Ceyhan B, LaMar J, Nategh P, Neghabi M, Konjalwar S, Rodriguez P, Hahn MK, Blakely RD, Ranji M. Optical Imaging Reveals Liver Metabolic Perturbations in Mblac1 Knockout Mice. Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual International Conference. 2023: 1-4. PMID 38083729 DOI: 10.1109/EMBC40787.2023.10341032 |
0.473 |
|
| 2022 |
Stewart A, Mayer FP, Gowrishankar R, Davis GL, Areal LB, Gresch PJ, Katamish RM, Peart R, Stilley SE, Spiess K, Rabil MJ, Diljohn FA, Wiggins AE, Vaughan RA, Hahn MK, et al. Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters. Molecular Psychiatry. PMID 36117213 DOI: 10.1038/s41380-022-01773-7 |
0.548 |
|
| 2020 |
Mayer FP, Iwamoto H, Hahn MK, Grumbar GJ, Stewart A, Li Y, Blakely RD. There's No Place Like Home? Return to the Home Cage Triggers Dopamine Release in the Mouse Nucleus Accumbens. Neurochemistry International. 104894. PMID 33161093 DOI: 10.1016/j.neuint.2020.104894 |
0.482 |
|
| 2020 |
Kelly E, Meng F, Fujita H, Morgado F, Kazemi Y, Rice LC, Ren C, Escamilla CO, Gibson JM, Sajadi S, Pendry RJ, Tan T, Ellegood J, Albert Basson M, Blakely RD, ... ... Hahn MK, et al. Regulation of autism-relevant behaviors by cerebellar-prefrontal cortical circuits. Nature Neuroscience. PMID 32661395 DOI: 10.1038/S41593-020-0665-Z |
0.434 |
|
| 2018 |
Stewart A, Davis GL, Gresch PJ, Katamish RM, Peart R, Rabil MJ, Gowrishankar R, Carroll FI, Hahn MK, Blakely RD. Serotonin transporter inhibition and 5-HT receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30578419 DOI: 10.1038/s41386-018-0301-8 |
0.487 |
|
| 2018 |
Gowrishankar R, Gresch PJ, Davis GL, Katamish RM, Riele JR, Stewart AM, Vaughan RA, Hahn MK, Blakely RD. Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D2 Autoreceptors Shapes the Impact of the Neuropsychiatric Disease-Associated DAT Variant Val559. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29739866 DOI: 10.1523/Jneurosci.0055-18.2018 |
0.599 |
|
| 2017 |
Davis GL, Stewart A, Stanwood GD, Gowrishankar R, Hahn MK, Blakely RD. Functional Coding Variation in the Presynaptic Dopamine Transporter Associated with Neuropsychiatric Disorders Drives Enhanced Motivation and Context-Dependent Impulsivity in Mice. Behavioural Brain Research. PMID 28964912 DOI: 10.1016/j.bbr.2017.09.043 |
0.617 |
|
| 2015 |
Kohli U, Diedrich A, Kannankeril PJ, Muszkat M, Sofowora GG, Hahn MK, English BA, Blakely RD, Stein CM, Kurnik D. Genetic Variation in Alpha2-Adrenoreceptors and Heart Rate Recovery after Exercise. Physiological Genomics. physiolgenomics.0012. PMID 26058836 DOI: 10.1152/Physiolgenomics.00124.2014 |
0.521 |
|
| 2014 |
Mergy MA, Gowrishankar R, Gresch PJ, Gantz SC, Williams J, Davis GL, Wheeler CA, Stanwood GD, Hahn MK, Blakely RD. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants. Proceedings of the National Academy of Sciences of the United States of America. 111: E4779-88. PMID 25331903 DOI: 10.1073/Pnas.1417294111 |
0.623 |
|
| 2014 |
Mergy MA, Gowrishankar R, Davis GL, Jessen TN, Wright J, Stanwood GD, Hahn MK, Blakely RD. Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder. Neurochemistry International. 73: 56-70. PMID 24332984 DOI: 10.1016/j.neuint.2013.11.009 |
0.606 |
|
| 2014 |
Gowrishankar R, Hahn MK, Blakely RD. Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders. Neurochemistry International. 73: 42-8. PMID 24231471 DOI: 10.1016/j.neuint.2013.10.016 |
0.597 |
|
| 2013 |
Fentress HM, Klar R, Krueger JJ, Sabb T, Redmon SN, Wallace NM, Shirey-Rice JK, Hahn MK. Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior. Genes, Brain, and Behavior. 12: 749-59. PMID 24102798 DOI: 10.1111/Gbb.12084 |
0.443 |
|
| 2013 |
Ma Y, Krueger JJ, Redmon SN, Uppuganti S, Nyman JS, Hahn MK, Elefteriou F. Extracellular norepinephrine clearance by the norepinephrine transporter is required for skeletal homeostasis. The Journal of Biological Chemistry. 288: 30105-13. PMID 24005671 DOI: 10.1074/Jbc.M113.481309 |
0.32 |
|
| 2013 |
Shirey-Rice JK, Klar R, Fentress HM, Redmon SN, Sabb TR, Krueger JJ, Wallace NM, Appalsamy M, Finney C, Lonce S, Diedrich A, Hahn MK. Norepinephrine transporter variant A457P knock-in mice display key features of human postural orthostatic tachycardia syndrome. Disease Models & Mechanisms. 6: 1001-11. PMID 23580201 DOI: 10.1242/Dmm.012203 |
0.425 |
|
| 2011 |
Kohli U, Hahn MK, English BA, Sofowora GG, Muszkat M, Li C, Blakely RD, Stein CM, Kurnik D. Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans. Pharmacogenetics and Genomics. 21: 171-8. PMID 21412203 DOI: 10.1097/Fpc.0B013E328344F63E |
0.524 |
|
| 2009 |
English BA, Hahn MK, Gizer IR, Mazei-Robison M, Steele A, Kurnik DM, Stein MA, Waldman ID, Blakely RD. Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. Journal of Neurodevelopmental Disorders. 1: 252-63. PMID 21547719 DOI: 10.1007/S11689-009-9033-8 |
0.705 |
|
| 2009 |
Hahn MK, Steele A, Couch RS, Stein MA, Krueger JJ. Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder. Neuropharmacology. 57: 694-701. PMID 19698724 DOI: 10.1016/j.neuropharm.2009.08.002 |
0.481 |
|
| 2008 |
Hahn MK, Blackford JU, Haman K, Mazei-Robison M, English BA, Prasad HC, Steele A, Hazelwood L, Fentress HM, Myers R, Blakely RD, Sanders-Bush E, Shelton R. Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Genes, Brain, and Behavior. 7: 487-95. PMID 18081710 DOI: 10.1111/J.1601-183X.2007.00384.X |
0.689 |
|
| 2007 |
Hahn MK, Blakely RD. The functional impact of SLC6 transporter genetic variation. Annual Review of Pharmacology and Toxicology. 47: 401-41. PMID 17067279 DOI: 10.1146/annurev.pharmtox.47.120505.105242 |
0.602 |
|
| 2006 |
Kim CH, Hahn MK, Joung Y, Anderson SL, Steele AH, Mazei-Robinson MS, Gizer I, Teicher MH, Cohen BM, Robertson D, Waldman ID, Blakely RD, Kim KS. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proceedings of the National Academy of Sciences of the United States of America. 103: 19164-9. PMID 17146058 DOI: 10.1073/Pnas.0510836103 |
0.597 |
|
| 2005 |
Nass R, Hahn MK, Jessen T, McDonald PW, Carvelli L, Blakely RD. A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking. Journal of Neurochemistry. 94: 774-85. PMID 15992384 DOI: 10.1111/j.1471-4159.2005.03205.x |
0.66 |
|
| 2005 |
Hahn MK, Mazei-Robison MS, Blakely RD. Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation. Molecular Pharmacology. 68: 457-66. PMID 15894713 DOI: 10.1124/mol.105.011270 |
0.716 |
|
| 2003 |
Hahn MK, Robertson D, Blakely RD. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 4470-8. PMID 12805287 |
0.552 |
|
| 2003 |
Hahn MK, Robertson D, Blakely RD. A Mutation in the Human Norepinephrine Transporter Gene (SLC6A2) Associated with Orthostatic Intolerance Disrupts Surface Expression of Mutant and Wild-Type Transporters The Journal of Neuroscience. 23: 4470-4478. DOI: 10.1523/Jneurosci.23-11-04470.2003 |
0.592 |
|
| 2002 |
Garland EM, Hahn MK, Ketch TP, Keller NR, Kim CH, Kim KS, Biaggioni I, Shannon JR, Blakely RD, Robertson D. Genetic basis of clinical catecholamine disorders. Annals of the New York Academy of Sciences. 971: 506-14. PMID 12438171 DOI: 10.1111/J.1749-6632.2002.Tb04515.X |
0.579 |
|
| 2002 |
Hahn MK, Blakely RD. Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. The Pharmacogenomics Journal. 2: 217-35. PMID 12196911 DOI: 10.1038/sj.tpj.6500106 |
0.632 |
|
| 1999 |
Hahn MK, Bannon MJ. Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation. Neuroscience. 94: 1183-8. PMID 10625057 DOI: 10.1016/S0306-4522(99)00319-X |
0.5 |
|
| 1998 |
Hahn MK, Bannon MJ. Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus. European Journal of Pharmacology. 348: 155-60. PMID 9652329 DOI: 10.1016/S0014-2999(98)00150-2 |
0.486 |
|
| Show low-probability matches. |